These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6696524)

  • 21. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
    Dawes PT; Fowler PD; Clarke S; Fisher J; Lawton A; Shadforth MF
    Br J Rheumatol; 1986 Feb; 25(1):44-9. PubMed ID: 3942847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 3-month changes in bone microstructure under anti-TNFα therapy in patients with rheumatoid arthritis using high-resolution peripheral quantitative computed tomography (HR-pQCT).
    Shimizu T; Choi HJ; Heilmeier U; Tanaka M; Burghardt AJ; Gong J; Chanchek N; Link TM; Graf J; Imboden JB; Li X
    Arthritis Res Ther; 2017 Oct; 19(1):222. PubMed ID: 28978352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Follow-up study in chronic polyarthritis as represented in roentgen image].
    Krahe T; Harder T; Mattern H; Leiendecker U
    Rofo; 1987 Sep; 147(3):271-8. PubMed ID: 2823331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
    Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
    Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prediction of radiological destruction during the early stage of rheumatoid arthritis.
    Luukkainen R; Kaarela K; Isomäki H; Martio J; Kiviniemi P; Räsänen J; Sarna S
    Clin Exp Rheumatol; 1983; 1(4):295-8. PubMed ID: 6681146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis.
    D'Elia HF; Larsen A; Mattsson LA; Waltbrand E; Kvist G; Mellström D; Saxne T; Ohlsson C; Nordborg E; Carlsten H
    J Rheumatol; 2003 Jul; 30(7):1456-63. PubMed ID: 12858441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis: workload and outcome over 10 years.
    Capell HA; Murphy EA; Hunter JA
    Q J Med; 1991 Jun; 79(290):461-76. PubMed ID: 1946927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.
    Skoumal M; Haberhauer G; Kolarz G; Hawa G; Woloszczuk W; Klingler A
    Arthritis Res Ther; 2005; 7(1):R65-70. PubMed ID: 15642144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.
    Scott DL; Bacon PA
    Rheumatol Int; 1985; 5(5):193-9. PubMed ID: 3906844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
    Machold KP; Stamm TA; Eberl GJ; Nell VK; Dunky A; Uffmann M; Smolen JS
    J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiologic assessment of benoxaprofen therapy in rheumatoid arthritis.
    Bluhm GB; Smith DW; Mikulaschek WM
    Eur J Rheumatol Inflamm; 1982; 5(2):186-97. PubMed ID: 7044795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic progress--review VI. Treatment of rheumatoid arthritis.
    Scott D; Scott D; Bacon P
    J Clin Hosp Pharm; 1982 Dec; 7(4):217-29. PubMed ID: 6761367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS).
    Dixey J; Solymossy C; Young A;
    J Rheumatol Suppl; 2004 Mar; 69():48-54. PubMed ID: 15053454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
    Garnero P; Landewé R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P
    Arthritis Rheum; 2002 Nov; 46(11):2847-56. PubMed ID: 12428224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
    Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictor of Hand Radiological Progression in Patients With Rheumatoid Arthritis Receiving TNF Antagonist Therapy by Change in Grayscale Synovitis-A Preliminary Study.
    Chen YC; Su FM; Hsu SW; Chen JF; Cheng TT; Lai HM; Chiu WC
    J Clin Rheumatol; 2017 Mar; 23(2):73-76. PubMed ID: 28212115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs.
    Choy EH; Kingsley GH; Khoshaba B; Pipitone N; Scott DL;
    Ann Rheum Dis; 2005 Sep; 64(9):1288-93. PubMed ID: 15760929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.